Research: Montefiore Einstein comprehensive Cancer Center awarded FDA grant for Clinical Trial on Experimental AML/MDS Treatment
Leading Researchers in Rare Blood Cancers to Investigate New Therapeutic Strategy that Targets Leukemic Stem Cells New York, Nov 29, 2023.- Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)—two related blood diseases that disproportionally strike older adults—are notoriously difficult to treat and associated with high relapse rates. Although new therapiesContinuar Leyendo


















